Project Scope |
This |
Project team will create a White Paper with recommendations for Treatment Emergent Definitions, with a focus on Phase 2-4 clinical trials. |
This White Paper will build upon a White Paper that outlines results from a survey on current practices, indicating variation that can likely be reduced. |
Recommendations will |
be based on the desired end-in-mind, and may or may not be consistent with current practices. |
Project Leads | Emails |
---|
Mary Nilsson
William Palo, Abbvie |
Nicola Newton, PHUSE Project |
Assistant |
Q3 2024 |
---|
|
Objectives & |
---|
Deliverables |
---|
Timelines |
---|
White Paper |